Maccioni
Giorgio Maccioni, Witten DE
Patent application number | Description | Published |
---|---|---|
20130229069 | CIRCUIT ARRANGEMENT HAVING AN EMERGENCY STOP SWITCH OF A HOIST - The invention relates to a circuit arrangement comprising a hoist controller ( | 09-05-2013 |
20130282178 | CONTROL METHOD FOR A BALANCING LIFTING GEAR AND BALANCING LIFTING GEAR - A control method for a balancing lifting gear which includes a lifting motor that can be actuated by a controller and uses a control handle with a force sensor to lift and lower a load-supporting device. In a “Balance” operating mode, the load-supporting device, with or without a picked-up load, is raised or lowered by the controller in response to a force applied by an operator. In order to ensure disturbance-free handling of a load when removing or attaching a load, a “Pick-up” operating mode or an “Assemble” operating mode is selected, in which the load-supporting device is moved independently without the influence of the force of the operator by the controller in the lifting or lowering direction in dependence upon the signals determined by the force sensor. A balancing lifting gear which operates in accordance with the aforementioned control method is also disclosed. | 10-24-2013 |
Ricardo Maccioni, Santiago CL
Patent application number | Description | Published |
---|---|---|
20110269793 | METHOD FOR PREVENTING TAU PROTEIN AGGREGATION AND TREATING ALZHEIMER'S DISEASE WITH A QUINOLINE DERIVATIVE COMPOUND - Method for the prevention of the tau protein aggregation and treating Alzheimer's disease by administering a quinoline derivative compound of formula | 11-03-2011 |
Ricardo B. Maccioni, Santiago CL
Patent application number | Description | Published |
---|---|---|
20120058573 | INNOVATIVE BLOOD PLATELETS BIOMARKER FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE - The present invention is directed to a method for early, non-invasive, rapid, efficient, reliable and accurate diagnose of Alzheimer's disease. The present invention particularly addresses obtaining blood samples, and stabilizing platelets from healthy persons and patients with probable cognitive impairment and/or Alzheimer's disease; extracting proteins from the platelets; identifying both monomeric and oligomeric tau proteins in the platelets with at least two monoclonal antibodies against the tau proteins, quantifying the amounts of the identified tau proteins, and comparing the amounts and protein profiles of the tau molecular species in the platelets of the healthy person and the patient. | 03-08-2012 |